Previous Page  15 / 25 Next Page
Information
Show Menu
Previous Page 15 / 25 Next Page
Page Background

PCOS 2018

Journal of Clinical and Molecular Endocrinology

ISSN: 2572-5432

Page 43

June 07-08, 2018

London, UK

4

th

World Congress on

Polycystic Ovarian

Syndrome

P

olycystic ovary syndrome is a disease which is recently

reported in one out of five women in genital ages are involved

(1); Author separates that polycystic ovary (PCO) belongs to a

pre-clinical condition which appears delayed menstrual circles,

even amenorrhea in some time; and Polycystic Ovary Syndrome

(PCOS) is a disease which has been exploring a sexual hormonal

disorder; both being gradually increasing incidences which have

become common causes of infertility. Among them, women with

severe PCOS are few, most of ladies lie PCO which is a gentle

state. Author identifies PCO and PCOS in three patterns: 1) Qi

deficiency of spleen and kidney, accumulation of fluid and stasis

of blood; 2) Kidney yang deficiency and accumulation of fluid

and phlegm; liver qi stagnation and blood stasis, according to

the clinical approach of TCM (traditional Chinese medicine) and

manage an effective treatment to regulate menstrual circle and

assist a pregnancy through acupuncture and Chinese herbal

medicine. Treating methods and typical cases which are treated

in the UK have been reported. Conclusion is that managing the

treating methods of TCM and taking diagnostic references from

conventional western medicine (CWM) can make the treatment

more distinctive and effective. Themethod of integratedTCMand

CWMwill raise efficacy of TCM rather than following its traditional

way. TCM will appear its advantage to treat the pre-clinical stage

of a severe disease and bar the organic disease’s occurrence,

hence helping women getting their regular menstrual cycles and

successful conceiving.

djiang52@hotmail.com

TCM treatment of polycystic ovary and polycystic ovary

syndrome

Dan Jiang

1, 2

1

Middlesex University London, UK

2

Hallam Institute of Chinese Medicine Sheffield, UK

J Clin Mol Endocrinol 2018, Volume 3

DOI: 10.21767/2572-5432-C1-003